NeurAxis (NRXS) Competitors $3.18 -0.03 (-0.78%) As of 11:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NRXS vs. NTRB, ZYXI, VANI, OM, HYPR, SURG, CTSO, ICCM, BSGM, and APTShould you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include Nutriband (NTRB), Zynex (ZYXI), Vivani Medical (VANI), Outset Medical (OM), Hyperfine (HYPR), SurgePays (SURG), Cytosorbents (CTSO), IceCure Medical (ICCM), BioSig Technologies (BSGM), and Alpha Pro Tech (APT). These companies are all part of the "medical equipment" industry. NeurAxis vs. Nutriband Zynex Vivani Medical Outset Medical Hyperfine SurgePays Cytosorbents IceCure Medical BioSig Technologies Alpha Pro Tech Nutriband (NASDAQ:NTRB) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, community ranking, analyst recommendations, profitability and dividends. Do analysts recommend NTRB or NRXS? Nutriband currently has a consensus target price of $13.00, indicating a potential upside of 139.90%. Given Nutriband's stronger consensus rating and higher possible upside, equities research analysts plainly believe Nutriband is more favorable than NeurAxis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nutriband 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NeurAxis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable valuation & earnings, NTRB or NRXS? Nutriband has higher earnings, but lower revenue than NeurAxis. Nutriband is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNutriband$2.14M28.25-$5.49M-$0.99-5.47NeurAxis$2.69M8.53-$14.63M-$1.19-2.67 Does the media refer more to NTRB or NRXS? In the previous week, NeurAxis had 8 more articles in the media than Nutriband. MarketBeat recorded 8 mentions for NeurAxis and 0 mentions for Nutriband. NeurAxis' average media sentiment score of 0.37 beat Nutriband's score of -0.59 indicating that NeurAxis is being referred to more favorably in the news media. Company Overall Sentiment Nutriband Negative NeurAxis Neutral Do institutionals & insiders have more ownership in NTRB or NRXS? 19.7% of Nutriband shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 54.1% of Nutriband shares are held by company insiders. Comparatively, 26.4% of NeurAxis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community favor NTRB or NRXS? Nutriband received 3 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 44.44% of users gave Nutriband an outperform vote. CompanyUnderperformOutperformNutribandOutperform Votes444.44% Underperform Votes555.56% NeurAxisOutperform Votes1100.00% Underperform VotesNo Votes Which has more volatility and risk, NTRB or NRXS? Nutriband has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, NeurAxis has a beta of 3.34, indicating that its stock price is 234% more volatile than the S&P 500. Is NTRB or NRXS more profitable? Nutriband has a net margin of -338.51% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Nutriband's return on equity.Company Net Margins Return on Equity Return on Assets Nutriband-338.51% -54.49% -48.52% NeurAxis -492.76%N/A -641.25% SummaryNutriband beats NeurAxis on 11 of the 18 factors compared between the two stocks. Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXS vs. The Competition Export to ExcelMetricNeurAxisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.08M$3.18B$5.31B$8.42BDividend YieldN/A1.72%5.21%4.10%P/E Ratio-1.7416.4826.7819.69Price / Sales8.5396.76386.97118.34Price / CashN/A44.0938.2534.62Price / Book-11.763.716.744.50Net Income-$14.63M$94.03M$3.23B$248.32M7 Day Performance34.53%0.85%1.49%-0.03%1 Month Performance60.35%23.52%11.47%12.72%1 Year Performance9.11%-12.16%16.57%7.38% NeurAxis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXSNeurAxisN/A$3.18-0.8%N/A+4.9%$23.08M$2.69M-1.7419News CoverageGap DownNTRBNutriband2.179 of 5 stars$5.83+1.9%$13.00+123.0%+9.2%$65.03M$2.14M-8.2110Positive NewsZYXIZynex3.0227 of 5 stars$2.15+3.9%$6.00+179.1%-78.5%$65.01M$172.40M14.33770VANIVivani Medical3.1257 of 5 stars$1.03-1.0%$4.00+288.3%-36.7%$61.02MN/A-2.2920News CoverageAnalyst ForecastAnalyst RevisionOMOutset Medical1.2424 of 5 stars$16.29+6.5%$24.67+51.4%-66.3%$58.56M$113.69M-6.57520Analyst ForecastGap DownHigh Trading VolumeHYPRHyperfine3.502 of 5 stars$0.73-1.9%$1.33+82.2%-33.5%$56.82M$12.89M-1.28190Analyst RevisionGap UpSURGSurgePays2.8471 of 5 stars$2.70-3.6%$8.75+224.1%-22.4%$55.11M$60.88M-2.3940CTSOCytosorbents2.0558 of 5 stars$0.87-0.1%$4.67+436.3%-7.4%$54.48M$35.59M-2.42220News CoverageAnalyst ForecastAnalyst RevisionICCMIceCure Medical2.0874 of 5 stars$0.97-5.8%$2.50+157.7%-5.5%$53.84M$3.29M-3.3460News CoverageUpcoming EarningsBSGMBioSig Technologies0.3704 of 5 stars$2.18+12.4%$2.50+14.7%+79.3%$52.87M$40,000.000.0050Earnings ReportGap UpHigh Trading VolumeAPTAlpha Pro TechN/A$4.53-3.2%N/A-10.6%$49.21M$57.84M12.24120 Related Companies and Tools Related Companies Nutriband Alternatives Zynex Alternatives Vivani Medical Alternatives Outset Medical Alternatives Hyperfine Alternatives SurgePays Alternatives Cytosorbents Alternatives IceCure Medical Alternatives BioSig Technologies Alternatives Alpha Pro Tech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRXS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NRXS Stock Free NRXS Stock Alerts